Becx MN, Hofland J, Krenning EP, Wyld DK, et al. A Multicenter Phase II Randomized Controlled Trial Comparing 177Lu-Dotatate/Capecitabine Combination Treatment with 177Lu-Dotatate Monotherapy in Patients with Neuroendocrine Tumors. Clin Cancer Res 2026;32:1424-1433.
PMID: 41591997